logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Haohai Biotechnology (06826.HK) spent 5.593 million Hong Kong dollars on November 21 to repurchase 206,000 shares.

date
21/11/2025
The Zhitong Financial APP reports that Haohai Bio-technology (06826.HK) announced that on November 21, 2025, it purchased 206,000 shares for HK$5.593 million.
Latest
2 m ago
Ha Air Conditioning (600202.SH) plans to list and transfer 40% equity of Fushan Chuan, further optimizing resource allocation.
2 m ago
The Yingmas Group (08136.HK) announced its interim financial performance. The net profit is 7.432 million Hong Kong dollars, a year-on-year decrease of 31.93%.
3 m ago
The Indian Nifty 50 index has dropped by 0.5% in the latest update.
3 m ago
Ukrainian government bonds continued to rise, with the purchase price of the 2035 maturity bond increasing by 1.3 cents to 51.85 cents.
4 m ago
The State Administration for Drug Control Issues Regulations on Inspection of Exported Drugs and Management of Export Certificates for Pharmaceutical Manufacturers.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.